Daratumumab granted breakthrough drug status
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.889681
Reference56 articles.
1. Human CD38: a glycoprotein in search of a function
2. Human CD38: a (r)evolutionary story of enzymes and receptors
3. Tetrameric Interaction of the Ectoenzyme CD38 on the Cell Surface Enables Its Catalytic and Raft-Association Activities
4. The Membrane-Bound Enzyme CD38 Exists in Two Opposing Orientations
5. Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope;Frontiers in Immunology;2024-08-13
2. The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review;Frontiers in Oncology;2023-10-24
3. A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies;International Journal of Molecular Sciences;2022-08-02
4. Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells;Journal of Experimental Medicine;2022-07-12
5. Expanding anti-CD38 immunotherapy for lymphoid malignancies;Journal of Experimental & Clinical Cancer Research;2022-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3